Ads

You May Also Like

Hemispherx Biopharma Enhances Ampligen Manufacturing and Scientific Capabilities

PHILADELPHIA, May 31, 2017 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) ("Hemispherx" or the ...

Ascendis Pharma A/S Reports Full Year 2017 Financial Results

- Rare Disease Endocrinology Pipeline Advances, with Significant Milestones Anticipated Over the Next Twelve ...